A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The “striking” findings showed an ...
Observational data suggested that men with nonmetastatic prostate cancer lived longer if they followed a healthier lifestyle. A higher prostate cancer behavior score was associated with reductions in ...
To earn CME related to this news article, click here. February 25, 2009 — A new joint guideline produced by the American Society of Clinical Oncology (ASCO) and the American Urological Association ...
A state-of-the-art laser prostate reduction operation is now being successfully delivered in the county as a day case procedure. HOLEP, or Holmium Laser Enucleation of the Prostate, is a minimally ...
Louisville, Kentucky--(Newsfile Corp. - May 19, 2025) - Aura Wellness today announced groundbreaking research demonstrating the effectiveness of its Pulsed Electromagnetic Field (PEMF) technology in ...
A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of ...
Expanded indication for AKEEGA® (niraparib and abiraterone acetate dual-action tablet) plus prednisone marks the first FDA-approved precision medicine combination treatment for patients with ...
Shares in CRISM Therapeutics rose 19% to 14p on Tuesday after the AIM-quoted drug delivery company reported positive ...
Researchers at Queen Mary University of London have found that the likelihood of prostate cancer overdiagnosis—the detection ...
To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/10373/251904_9ea3c480f4166aa2_001full.jpg "My family has a history of ...